HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Tingyu Wen Selected Research
Tingyu Wen Research Topics
Disease
4
Neoplasms (Cancer)
03/2023 - 01/2021
1
Thrombosis (Thrombus)
02/2024
1
Carcinoma (Carcinomatosis)
01/2023
1
Lymphoma (Lymphomas)
01/2023
1
T-Cell Lymphoma (Lymphoma, T Cell)
01/2023
1
Ductal Carcinoma
01/2023
1
Squamous Cell Carcinoma of Head and Neck
09/2022
1
Breast Neoplasms (Breast Cancer)
12/2021
1
Colorectal Neoplasms (Colorectal Cancer)
01/2021
1
Infections
01/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
03/2017
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
03/2023 - 12/2021
1
theasinensin A
IBA
02/2024
1
2- cyclohexylidenhydrazo- 4- phenyl- thiazole
IBA
02/2024
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
03/2023
1
Histone Deacetylase Inhibitors
IBA
01/2023
1
N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamide
IBA
01/2023
1
Histone Deacetylases (Histone Deacetylase)
IBA
01/2023
1
Chemokines
IBA
01/2023
1
Proteins (Proteins, Gene)
FDA Link
12/2021
1
honokiol
IBA
01/2021
1
magnolol
IBA
01/2021
1
Circular RNA
IBA
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021
1
ibrutinib
IBA
01/2021
1
Agammaglobulinaemia Tyrosine Kinase
IBA
01/2021
1
Sorafenib (BAY 43-9006)
FDA Link
03/2017
1
Sunitinib (Sutent)
FDA Link
03/2017
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
03/2017
Therapy/Procedure
2
Therapeutics
01/2023 - 03/2017
1
Immunotherapy
01/2023
1
Radiotherapy
01/2023
1
Adjuvant Chemotherapy
09/2022
1
Drug Therapy (Chemotherapy)
01/2021